Ticker brief

SLS SELLAS LIFE SCIENCES GROUP I

Consumer, Non-cyclical · Pharmaceuticals

last close
$14.98
1 day
+12.9%
14 days
+86.1%
mkt cap
$2.9B
signals 14d
82
authors 14d
27
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-07-02 · now +0.30 (−1 bearish … +1 bullish)
Who spoke27
authorgradetrader scoresignalsmean sent
@SuperDuperInvstC-2.3225+0.60
@2000STOCKMASTERC-4.197+0.42
@Brad_E_SchulzC·6+0.18
@buzztickrC·4+0.20
@Flourish_VenkatC-1.044+0.59
@PSInvestorB+1.554+0.64
@OptionsFlowBossC·3+0.23
@PK_FundC+0.193+0.67
@SandmanMarketsC-2.282+0.35
@SeegerErikC-1.012+0.33
@HedgeFundTipsB-0.752+0.05
@schaeffersC-3.722+0.10
@Maximus_HollaC-0.482-0.02
@Volume_StocksC-2.802-0.08
@YYDSxjmB+0.192+0.58
@fundmyfundB-2.011+0.40
@SakaKabu5924C-0.631+0.20
@TautilasC-0.631+0.00
@MikeJTradesC·1+0.55
@Bezel4455C-2.521+0.45
@RosannaInvestsB+0.071+0.10
@TrendSpiderC-0.581+0.65
@matt2centsC-2.521+0.00
@UMiLiveOfficialC·1+0.45
@onestoplossC-2.291+0.65
Recent signals30of 82 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-07-02@Brad_E_Schulz+0.15Category overview of tracked stocks with sector gainers.
2026-07-02@buzztickr+0.20Daily breakout watchlist with spotted/current prices, returns, and mention counts.
2026-07-02@SuperDuperInvst+0.50Says load up VNDA at $6. — Urges loading VNDA and compares to prior winners SLS, LUNR and RKLB.
2026-07-02@SuperDuperInvst+0.75Speculates on buyout or merger news next week for SLS.
2026-07-02@Sir_Kory+0.10Speculative setup could move from $3 toward $5-6 before catalysts — States tactical setup and target move into catalysts.
2026-07-02@SuperDuperInvst+0.40Get in VNDA before big buyers arrive. — Says VNDA will rise like SLS and urges getting in.
2026-07-02@HedgeFundTips+0.00Asks where money is flowing today and lists many tickers with a link but no stance.
2026-07-01@SuperDuperInvst+0.35References past SLS pick and BlackRock 5% stake while hyping unnamed future picks.+12.9%
2026-07-01@Volume_Stocks-0.15Lists Stocktwits top trending stocks with percentage moves.+12.9%
2026-07-01@buzztickr+0.00Market pulse mention for SLS with chart/link but no standalone stance.+12.9%
2026-07-01@YYDSxjm+0.75Says once SLS flies and FDA approves, it will not come back down.+12.9%
2026-06-30@SuperDuperInvst+0.45Teases an undisclosed future stock pick and compares it to SLS runner.+1.5%
2026-06-30@SuperDuperInvst+0.80Celebrates SLS run from under $1.80 to $16.50+ today.+1.5%
2026-06-30@SuperDuperInvst+0.50Recaps green day and named holdings/stocks being on fire.+1.5%
2026-06-30@cfaryanoconnell+0.00Lists options with increasing implied volatility.+1.5%
2026-06-30@2000STOCKMASTER-0.55High early volume while price is being smashed is called not a good sign.+1.5%
2026-06-30@onestoploss+0.65Says if choosing a biotech investment today, SLS would likely be one, high risk/high reward.+1.5%
2026-06-30@UMiLiveOfficial+0.45Higher highs/lows, expanding volume, and strong weekly close define healthy uptrend.+1.5%
2026-06-30@YYDSxjm+0.40Past-tense squeeze/gain framing with 261.25% and mockery of shorts.+1.5%
2026-06-30@PK_Fund+0.65Calls SLS still grossly undervalued despite market cap rising to roughly $3B.+1.5%
2026-06-30@Volume_Stocks+0.00UPC up 311% after announced share purchase agreement to acquire Best Praise for $10.75M.+1.5%
2026-06-30@matt2cents+0.00Lists market/index and stock price moves, but ticker stance unclear.+1.5%
2026-06-30@2000STOCKMASTER+0.50Celebratory ticker-only bullish expression.+1.5%
2026-06-29@TrendSpider+0.65SLS volume highest in 5 years, shares up 67% in 3 days, near 40% short interest.-3.0%
2026-06-29@RosannaInvests+0.10AI drug discovery basket thesis names RXRX as cleanest expression with other buckets.-3.0%
2026-06-29@Brad_E_Schulz+0.10Sector performance table with percent moves and breadth counts.-3.0%
2026-06-29@Brad_E_Schulz+0.15Lists stocks up at least 4% on elevated volume with exact AV and move data.-3.0%
2026-06-29@SuperDuperInvst+0.50Recaps prior SLS load-up call and asks to check price now.-3.0%
2026-06-29@SuperDuperInvst+0.40Do not miss VNDA at $6 for LT rally to $25-$75 — Uses SLS recap to make forward bullish VNDA long-term target.-3.0%
2026-06-29@Maximus_Holla+0.60Author suggests ABVX should buy SLS and SLS could be bought for 500 per share.-3.0%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.